• DOI:10.1007/S101560050001
Corpus ID: 38981498

Semisynthetic aminoglycoside antibiotics: Development and enzymatic modifications

@article{Kondo1999SemisyntheticAA,
  title={Semisynthetic aminoglycoside antibiotics: Development and enzymatic modifications},
  author={S. Kondo and K. Hotta},
  journal={Journal of Infection and Chemotherapy},
  year={1999},
  volume={5},
  pages={1-9}
}

S. Kondo, K. Hotta

Published 1999

Biology, Medicine

Journal of Infection and Chemotherapy

Abstract The critical resistance mechanisms of aminoglycoside antibiotics in bacteria of clinical importance are the enzymatic N-acetylation, O-phosphorylation, and O-nucleotidylation that generally result in the inactivation of aminoglycosides. To overcome such resistance mechanisms, dibekacin (3′,4′-dideoxykanamycin B) was developed as the first rationally designed semisynthetic aminoglycoside, based on the enzymatic 3′-O-phosphorylation of kanamycin. Subsequently, amikacin, netilmicin, and… CONTINUE READING

View on Springer

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed